Clinical Trials · NCT00736229
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Saint Luke's Health System
- Enrollment
- 40
- Start date
- Aug 2008
- Locations
- 1 site, United States
- Primary endpoint
- Median Glucose Values From Steady State Through 48 Hours or Until Discharge.